Miraj T Patel
Examiner (ID: 3971)
Most Active Art Unit | 3655 |
Art Unit(s) | 3655 |
Total Applications | 57 |
Issued Applications | 21 |
Pending Applications | 27 |
Abandoned Applications | 9 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 14497995
[patent_doc_number] => 20190192652
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-27
[patent_title] => PEANUT FORMULATIONS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/289370
[patent_app_country] => US
[patent_app_date] => 2019-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 47086
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16289370
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/289370 | Peanut formulations and used thereof | Feb 27, 2019 | Issued |
Array
(
[id] => 15191355
[patent_doc_number] => 10493148
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-12-03
[patent_title] => PD-1 agonist antibodies and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/282609
[patent_app_country] => US
[patent_app_date] => 2019-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11908
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16282609
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/282609 | PD-1 agonist antibodies and uses thereof | Feb 21, 2019 | Issued |
Array
(
[id] => 17505205
[patent_doc_number] => 20220098307
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-31
[patent_title] => MODIFIED FC FRAGMENT, ANTIBODY COMPRISING SAME, AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/432705
[patent_app_country] => US
[patent_app_date] => 2019-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45924
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17432705
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/432705 | MODIFIED FC FRAGMENT, ANTIBODY COMPRISING SAME, AND APPLICATION THEREOF | Feb 21, 2019 | Pending |
Array
(
[id] => 14993797
[patent_doc_number] => 20190315856
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-17
[patent_title] => Antibodies That Bind Human Cannabinoid 1 (CB1) Receptor
[patent_app_type] => utility
[patent_app_number] => 16/257511
[patent_app_country] => US
[patent_app_date] => 2019-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41905
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16257511
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/257511 | Treatment of disease responsive to modulation of cannabanoid 1(CB1) receptor signaling | Jan 24, 2019 | Issued |
Array
(
[id] => 15293673
[patent_doc_number] => 20190389972
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-26
[patent_title] => MODIFIED CK AND CH1 DOMAINS
[patent_app_type] => utility
[patent_app_number] => 16/489970
[patent_app_country] => US
[patent_app_date] => 2019-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20613
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16489970
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/489970 | MODIFIED CK AND CH1 DOMAINS | Jan 14, 2019 | Pending |
Array
(
[id] => 16105675
[patent_doc_number] => 10695422
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-30
[patent_title] => Mixed allergen compositions and methods for using the same
[patent_app_type] => utility
[patent_app_number] => 16/245650
[patent_app_country] => US
[patent_app_date] => 2019-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 13887
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16245650
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/245650 | Mixed allergen compositions and methods for using the same | Jan 10, 2019 | Issued |
Array
(
[id] => 14808415
[patent_doc_number] => 20190270817
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-05
[patent_title] => Anti-PD-1 Antibodies and Methods of Treatment
[patent_app_type] => utility
[patent_app_number] => 16/245733
[patent_app_country] => US
[patent_app_date] => 2019-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 78295
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 356
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16245733
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/245733 | Anti-PD-1 antibodies and methods of treatment | Jan 10, 2019 | Issued |
Array
(
[id] => 17828404
[patent_doc_number] => 20220265708
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-25
[patent_title] => Modified Cell Expansion and Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 16/961418
[patent_app_country] => US
[patent_app_date] => 2019-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37684
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16961418
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/961418 | Modified Cell Expansion and Uses Thereof | Jan 9, 2019 | Pending |
Array
(
[id] => 15209855
[patent_doc_number] => 20190367614
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-05
[patent_title] => ANTI-PD-1 SCFVS
[patent_app_type] => utility
[patent_app_number] => 16/242417
[patent_app_country] => US
[patent_app_date] => 2019-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11969
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16242417
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/242417 | ANTI-PD-1 SCFVS | Jan 7, 2019 | Abandoned |
Array
(
[id] => 18443601
[patent_doc_number] => 11679152
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-06-20
[patent_title] => Recombinant hypoallergenic Equ c 1 polypeptides for use in the immunotherapy of horse allergy
[patent_app_type] => utility
[patent_app_number] => 16/959156
[patent_app_country] => US
[patent_app_date] => 2019-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 5668
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 82
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16959156
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/959156 | Recombinant hypoallergenic Equ c 1 polypeptides for use in the immunotherapy of horse allergy | Jan 3, 2019 | Issued |
Array
(
[id] => 16673137
[patent_doc_number] => 20210061900
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-04
[patent_title] => ANTIBODIES AND ASSAYS FOR CCL14
[patent_app_type] => utility
[patent_app_number] => 16/958072
[patent_app_country] => US
[patent_app_date] => 2018-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28761
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -48
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16958072
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/958072 | Antibodies and assays for CCL14 | Dec 27, 2018 | Issued |
Array
(
[id] => 15206397
[patent_doc_number] => 20190365885
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-05
[patent_title] => MIXED ALLERGEN COMPOSITIONS AND METHODS FOR USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/228953
[patent_app_country] => US
[patent_app_date] => 2018-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14738
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16228953
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/228953 | Mixed allergen compositions and methods for using the same | Dec 20, 2018 | Issued |
Array
(
[id] => 14273829
[patent_doc_number] => 20190134199
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-09
[patent_title] => METHOD FOR THE PRODUCTION OF HYDROLYZED ALLERGENS
[patent_app_type] => utility
[patent_app_number] => 16/231149
[patent_app_country] => US
[patent_app_date] => 2018-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5492
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 172
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16231149
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/231149 | METHOD FOR THE PRODUCTION OF HYDROLYZED ALLERGENS | Dec 20, 2018 | Abandoned |
Array
(
[id] => 18666290
[patent_doc_number] => 11773168
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-10-03
[patent_title] => FcRn antibodies and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 16/771147
[patent_app_country] => US
[patent_app_date] => 2018-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 34
[patent_no_of_words] => 34282
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16771147
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/771147 | FcRn antibodies and methods of use thereof | Dec 12, 2018 | Issued |
Array
(
[id] => 16483970
[patent_doc_number] => 20200377571
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-03
[patent_title] => MULTISPECIFIC MOLECULES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/770467
[patent_app_country] => US
[patent_app_date] => 2018-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50087
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -67
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16770467
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/770467 | MULTISPECIFIC MOLECULES AND USES THEREOF | Dec 6, 2018 | Pending |
Array
(
[id] => 17220630
[patent_doc_number] => 11173113
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-16
[patent_title] => Composition and method for reducing allergic response
[patent_app_type] => utility
[patent_app_number] => 16/197919
[patent_app_country] => US
[patent_app_date] => 2018-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5900
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 178
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16197919
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/197919 | Composition and method for reducing allergic response | Nov 20, 2018 | Issued |
Array
(
[id] => 16297750
[patent_doc_number] => 20200283473
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-10
[patent_title] => ANTIBODY PURIFICATION
[patent_app_type] => utility
[patent_app_number] => 16/763863
[patent_app_country] => US
[patent_app_date] => 2018-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32593
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16763863
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/763863 | Antibody purification | Nov 12, 2018 | Issued |
Array
(
[id] => 17695974
[patent_doc_number] => 11369676
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-28
[patent_title] => Methods of oral immunotherapy
[patent_app_type] => utility
[patent_app_number] => 16/178502
[patent_app_country] => US
[patent_app_date] => 2018-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 12
[patent_no_of_words] => 40618
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16178502
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/178502 | Methods of oral immunotherapy | Oct 31, 2018 | Issued |
Array
(
[id] => 13982575
[patent_doc_number] => 20190060445
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-28
[patent_title] => MIXED ALLERGEN COMPOSITIONS AND METHODS FOR USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/171887
[patent_app_country] => US
[patent_app_date] => 2018-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13966
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16171887
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/171887 | Mixed allergen compositions and methods for using the same | Oct 25, 2018 | Issued |
Array
(
[id] => 13982573
[patent_doc_number] => 20190060444
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-28
[patent_title] => MIXED ALLERGEN COMPOSITIONS AND METHODS FOR USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/171874
[patent_app_country] => US
[patent_app_date] => 2018-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13864
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16171874
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/171874 | Mixed allergen compositions and methods for using the same | Oct 25, 2018 | Issued |